Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03336918 · ClinicalTrials.gov registry record
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
A clinical trial of Depression and Bipolar Disorder, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT03336918 is a study of Depression and Bipolar Disorder that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 120 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03336918, a study of Depression and Bipolar Disorder, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Lithium is highly effective in the treatment of bipolar disorder. This study aims to investigate, for the first time, the impact of lithium monotherapy on the structural and functional connectivity of the brain using MRI imaging.
Conditions Studied
Interventions
- DRUG Lithium
Study Locations (1)
Ohio
- Cleveland Clinic Foundation Center for Behavioral Health - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-12-07 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03336918
The ClinicalTrials.gov registry entry for NCT03336918 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Lithium is the first listed.
NCT03336918 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03336918 about?
NCT03336918 is a clinical study titled "Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder". Lithium is highly effective in the treatment of bipolar disorder. This study aims to investigate, for the first time, the impact of lithium monotherapy on the structural and functional connectivity of the brain using MRI imaging.
What is the current status of trial NCT03336918?
This trial is currently active not recruiting. The enrollment target is 120 participants. The study started on 2017-12-07. Estimated completion is 2026-06-01.
What conditions does trial NCT03336918 study?
This clinical trial studies the following conditions: Depression, Bipolar Disorder, Bipolar Depression, Major Depressive Episode, Bipolar I Depression.
What interventions are being tested in trial NCT03336918?
The interventions under investigation include: Lithium (DRUG).
Who is sponsoring clinical trial NCT03336918?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03336918 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.